International migrants in Australia and beyond are at increased risk of HIV infection due to reduced access to a highly effective prevention measure, a world-first global review led by Monash University has found.
Jul 6, 2023
0
18
For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.
Jul 5, 2023
0
16
A study of publicly insured adults living with HIV found that long-acting injectable antiretroviral therapy (LA-ART) with cabotegravir (CAB) and rilpivirine (RPV) achieved virologic suppression among most people with detectable ...
Jul 3, 2023
0
3
The COVID-19 pandemic had substantial psychological impacts on the nation and around the world. New research shows patients with HIV were particularly susceptible to psychosocial challenges like depression, anxiety, substance ...
Jun 29, 2023
0
1
Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.
Jun 29, 2023
1
15
Meningococcal disease—which includes meningitis—appears to be on the rise among Americans infected with HIV, new research reveals.
Jun 29, 2023
0
56
It's not making major news headlines like in the '80s, but HIV remains a significant health concern. About 38 million people are living with HIV, the virus that causes AIDS, according to the World Health Organization.
Jun 28, 2023
0
25
It's been over a decade since the FDA approved the first Pre-Exposure Prophylaxis (PrEP) medication for HIV prevention in 2012. Now available in the U.S. as a daily pill or every-two-months injection, the antiretroviral treatment ...
Jun 27, 2023
0
10
Africa's contribution to global HIV research is relatively low compared to its burden of infection, according to a study published online June 22 in PLOS Global Public Health.
Jun 26, 2023
1
1
For patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI), according to a study published in the June 22 issue ...
Jun 23, 2023
0
2
